Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

3 Small-Cap Stocks With Substantial Growth Potential fo 2024

By Muslim Farooque, InvestorPlace Contributor
Explore small-cap stocks with growth potential, ready to outperform in 2024, and fueled by a robust economic backdrop.

Why Is Argenx (ARGX) Stock Down 25% Today?

By Josh Enomoto, InvestorPlace Contributor
Following a late-stage clinical disappointment, Argenx has been forced back to the drawing board, thus cratering ARGX stock.

3 Penny Stocks You’ll Regret Not Buying Soon: December Edition

By Matthew Farley, InvestorPlace Contributor
Consider the pros and cons of buying these penny stocks, which can deliver risk-adjusted returns to investors' portfolios.

3 Potential Turnaround Stocks to Buy for Big Rewards in 2024

By Ian Cooper, InvestorPlace Contributor
There was plenty to get excited about in 2023 and even more to get excited about with turnaround stocks in the new year.

Canopy Growth Just Enacted a 1-for-10 Reverse Split of CGC Stock

By Dana Blankenhorn, InvestorPlace Contributor
Profits have proven elusive in the marijuana sector. Canopy rival Tilray Brands has shifted its attention to beer. CGC stock has languished.

3 Cannabis Stocks You’ll Regret Not Buying Soon: December Edition

By Ian Cooper, InvestorPlace Contributor
With the U.S. elections just months away, cannabis could be a hot button issue, and could send related cannabis stocks to higher highs.

CRSP Stock Alert: CRISPR Therapeutics Is Losing Its Medical Chief

By Dana Blankenhorn, InvestorPlace Contributor
The fate of Crispr and CRSP stock will be determined by the success of other drugs in the company's pipeline rather than Casgevy.

3 Stocks to Snatch Up on Tax-Loss Harvesting Dips

By Yiannis Zourmpanos, InvestorPlace Contributor
Tax-loss harvesting serves as a strategic financial tactic employed by investors to leverage market downturns for potential gains.

3 Stocks Destined for Trillion-Dollar Glory in the Near Future

By Muslim Farooque, InvestorPlace Contributor
These inevitable trillion-dollar stocks are poised for glory, thriving in a robust U.S. economy with standout growth and innovation.

Don’t Waste Another Minute: Dump These 3 F-Rated Stocks Now

By Noah Bolton, InvestorPlace Contributor
Avoid these f-rated stocks like the plague in order to help keep your portfolio squeaky clean in the new year.

Why Is Compugen (CGEN) Stock Up 189% Today?

By William White, InvestorPlace Writer
Compugen stock is up on Tuesday as investors in CGEN shares react to an exclusive licensing agreement with Gilead Sciences.

Why Is Etao International (ETAO) Stock Down 37% Today?

By William White, InvestorPlace Writer
Etao International stock is falling hard on Tuesday as investor sin ETAO react to a new delisting update from the Nasdaq Exchange.

Why Is Motus GI (MOTS) Stock Down 44% Today?

By William White, InvestorPlace Writer
Motus GI stock is falling on Tuesday after the medical technology company announced pricing for a public offering of MOTS shares.

Why Is LogicMark (LGMK) Stock Up 52% Today?

By William White, InvestorPlace Writer
LogicMark stock is up on Tuesday with heavy trading of LGMK shares despite a lack of news from the personal technology company.

Forget Tech! 7 Underrated Growth Stocks for Investors

By Thomas Niel, InvestorPlace Contributor
Seize the opportunity with each of these seven top growth stocks, all of which are in industries out of the tech sector.

3 Stocks That Just Hit a 52-Week Low. Time to Back Up the Truck?

By Rich Duprey, InvestorPlace Contributor
Investors still need to look at the business when searching for stocks to buy at a 52-week low because the business model may be broken.

Want to Turn Spare Change Into $1,000? Buy These 3 Stocks Now

By Omor Ibne Ehsan
Three high conviction stocks seem perfect for opportunistic investors and could quickly transform spare change into four-figure returns.

Why Is Minerva Surgical (UTRS) Stock Down 50% Today?

By William White, InvestorPlace Writer
Minerva Surgical stock is falling hard on Monday after the women's healthcare company announced plans to delist UTRS shares.

Bull Run Bonanza: Top 3 Penny Stocks Primed for Explosive Growth

By Yiannis Zourmpanos, InvestorPlace Contributor
In the labyrinth of the stock market, discovering hidden gems often promises exhilarating prospects.
Load More Articles